Jason Camm

Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California.

The Thiel Foundation awards grants to groups that empower people to improve their lives, champions organizations and individuals who expose human rights abuses and authoritarianism. It programs include The Thiel Fellowship, Breakout Labs and Imitatio. The company is headquartered in San Francisco, CA.

Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation.

Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation.

Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California.

Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California.

Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California.

The Thiel Foundation awards grants to groups that empower people to improve their lives, champions organizations and individuals who expose human rights abuses and authoritarianism. It programs include The Thiel Fellowship, Breakout Labs and Imitatio. The company is headquartered in San Francisco, CA.

ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany.

ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany.

Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA.

Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA.

ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany.

Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California.

Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation.

Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA.

Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California.

Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation.

Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California.

ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel.

Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California.

Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California.

Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California.

Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California.

Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California.

Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California.

Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA.

Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation.

Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California.

The Thiel Foundation awards grants to groups that empower people to improve their lives, champions organizations and individuals who expose human rights abuses and authoritarianism. It programs include The Thiel Fellowship, Breakout Labs and Imitatio. The company is headquartered in San Francisco, CA.

Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California.

ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel.

Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation.

The Thiel Foundation awards grants to groups that empower people to improve their lives, champions organizations and individuals who expose human rights abuses and authoritarianism. It programs include The Thiel Fellowship, Breakout Labs and Imitatio. The company is headquartered in San Francisco, CA.

Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation.

ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel.

The Thiel Foundation awards grants to groups that empower people to improve their lives, champions organizations and individuals who expose human rights abuses and authoritarianism. It programs include The Thiel Fellowship, Breakout Labs and Imitatio. The company is headquartered in San Francisco, CA.

Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA.

The Thiel Foundation awards grants to groups that empower people to improve their lives, champions organizations and individuals who expose human rights abuses and authoritarianism. It programs include The Thiel Fellowship, Breakout Labs and Imitatio. The company is headquartered in San Francisco, CA.

The Thiel Foundation awards grants to groups that empower people to improve their lives, champions organizations and individuals who expose human rights abuses and authoritarianism. It programs include The Thiel Fellowship, Breakout Labs and Imitatio. The company is headquartered in San Francisco, CA.

The Thiel Foundation awards grants to groups that empower people to improve their lives, champions organizations and individuals who expose human rights abuses and authoritarianism. It programs include The Thiel Fellowship, Breakout Labs and Imitatio. The company is headquartered in San Francisco, CA.

Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation.

Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA.

Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation.

Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA.

Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation.

The Thiel Foundation awards grants to groups that empower people to improve their lives, champions organizations and individuals who expose human rights abuses and authoritarianism. It programs include The Thiel Fellowship, Breakout Labs and Imitatio. The company is headquartered in San Francisco, CA.

Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation.